Nanohale, a German firm developing new formulations of protein and peptide therapeutics, has acquired the R&D and contract development and manufacturing services assets of Scil Technology, bringing them into a new wholly owned subsidiary called Formycon.
Scil Technology itself will remain as an independent company with rights to the tissue regeneration projects outlicensed to Medtronic (the...